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Brain glucosensing is essential for normal body glucose homeostasis and neuronal function. 
However, the exact signaling mechanisms involved in the neuronal sensing of extracellular 
glucose levels remain poorly understood. Of particular interest is the identiﬁ  cation of candidate 
membrane molecular sensors that would allow neurons to change ﬁ  ring rates independently 
of intracellular glucose metabolism. Here we describe for the ﬁ  rst time the expression of the 
taste receptor genes Tas1r1, Tas1r2 and Tas1r3, and their associated G-protein genes, in the 
mammalian brain. Neuronal expression of taste genes was detected in different nutrient-sensing 
forebrain regions, including the paraventricular and arcuate nuclei of the hypothalamus, the CA 
ﬁ  elds and dentate gyrus of the hippocampus, the habenula, and cortex. Expression was also 
observed in the intra-ventricular epithelial cells of the choroid plexus. These same regions were 
found to express the corresponding gene products that form the heterodimeric T1R2/T1R3 
and T1R1/T1R3 sweet and L-amino acid taste G-protein coupled receptors, respectively, along 
with the taste G-protein α-gustducin. Moreover, in vivo studies in mice demonstrated that 
the hypothalamic expression of taste-related genes is regulated by the nutritional state of the 
animal, with food deprivation signiﬁ  cantly increasing expression levels of Tas1r1 and Tas1r2 in 
hypothalamus, but not in cortex. Furthermore, exposing mouse hypothalamic cells to a low-
glucose medium, while maintaining normal L-amino acid concentrations, speciﬁ  cally resulted 
in higher expression levels of the sweet-associated gene Tas1r2. This latter effect was reversed 
by adding the non-metabolizable artiﬁ  cial sweetener sucralose to the low-glucose medium, 
indicating that taste-like signaling in hypothalamic neurons does not require intracellular glucose 
oxidation. Taken together, our ﬁ  ndings suggest that the heterodimeric G-protein coupled sweet 
receptor T1R2/T1R3 is a candidate membrane-bound brain glucosensor.
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 pancreatic islets, glucose is carried into the cell through facilitated 
transport via GLUT proteins, resulting in equilibration between 
extracellular and cytosolic glucose (McCrimmon, 2008). In these 
cells, intracellular glucose metabolism is controlled by glucokinase 
(GK), the rate-limiting factor in glycolysis (Matschinsky, 1996; 
Schuit et al., 2001). The action of GK on glucose results in a series 
of intracellular events eventually leading to rises in the cytosolic 
ATP:ADP ratio and subsequent closure of ATP-sensitive potas-
sium (KATP) channels, which in turn causes cell depolarization 
(Gonzalez et al., 2008; McCrimmon, 2008). The discovery that 
both GK and KATP are expressed in glucosensing regions of the 
brain then naturally led to the hypothesis that GK and KATP, like 
in pancreas, play essential roles in the generation of GE responses 
to rises in extracellular glucose (Ashford et al., 1990; Kang et al., 
2006; Routh, 2002).
However, several lines of evidence strongly suggest that glu-
cosensing neurons might use alternative, GK/KATP-independent 
pathways to respond to local ﬂ  uctuations in glucose levels. For 
example, rises in glucose concentration at physiological levels fail 
to elevate cytosolic ATP levels in the hypothalamus (Ainscow et al., 
INTRODUCTION
Brain glucosensors are specialized neurons that respond to local 
ﬂ  uctuations in extracellular glucose levels, modulating their mean 
ﬁ  ring rate according to changes in glucose concentration (Gonzalez 
et al., 2008; McCrimmon, 2008). Early electrophysiological studies 
described the presence of glucosensing neurons in brain regions 
known to inﬂ  uence glucose homeostasis, including the hypotha-
lamus and the brainstem (Anand et al., 1964; Oomura et al., 1969; 
Ritter et al., 1981). Later studies have identiﬁ  ed the presence of 
glucosensing neurons in other brain regions including the amy-
gdala (Nakano et al., 1986), septum (Shoji, 1992) and cortex (Lee 
et al., 1996).
How is glucose sensed by neurons? Glucosensing neurons 
are generally classiﬁ  ed as “glucose-excited” (GE) or “glucose-
  inhibited” (GI), according to whether their mean ﬁ  ring rate 
increase or decrease, respectively, in response to local changes 
in extracellular glucose (Gonzalez et  al., 2008; McCrimmon, 
2008). In the case of GE neurons, the insulin-secreting β-cells of 
the pancreas have been adopted as the cellular model of neuro-
nal glucosensing (Matschinsky, 1996; Schuit et al., 2001). In the 
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2002). In addition, KATP channels are expressed in several regions 
of the brain, most often in non-glucosensing neurons (Karschin 
et al., 1997). Another compelling evidence in favor of the exist-
ence non-metabolic glucosensing pathways in the brain relates 
to the lack of expression of pancreatic glucosensor elements in a 
signiﬁ  cant fraction of glucosensing neurons; in fact, over 30% of 
glucosensing neurons were found to not express GK or SUR1, a 
subunit of the pancreatic β-cell KATP channels (Kang et al., 2004). 
These results have recently led to the hypothesis that the primary 
role of GK in neurons relates to cellular metabolic support rather 
than glucosensing per se (Gonzalez et al., 2008, 2009). Finally, it 
is noticeable that GE neurons are present in the hypothalamus of 
KATP channel knockout (Kir6.2 null) mice (Fioramonti et al., 2004). 
Likewise the GE case, GI neurons also seem to make use of GK-
independent pathways. In addition to the fact that only a fraction of 
GI neurons are found to express GK (Kang et al., 2004), stimulating 
ATP production via lactate infusions did not result in inhibition 
of hypothalamic GI neurons (Song and Routh, 2005). Moreover, 
while inhibition of orexin GI neurons by glucose was shown to 
depend on tandem-pore K2P ion channels (Burdakov et al., 2006), 
the same study also demonstrates that intracellular applications 
of glucose did not affect the extracellular action of glucose, sug-
gesting that glucose acts extracellularly on currently undetermined 
glucose sensors located on the cell membrane (Burdakov et al., 
2006). Overall, it must be concluded from the above that at least 
part of the mechanism regulating neuronal glucosensing involves 
signaling pathways that do not require intracellular metabolic 
processing of glucose.
In this study, we propose that one of the metabolism-
  independent mechanisms that GE and GI neurons might use to 
respond to local changes in extracellular glucose levels involves a 
sweet taste-like signaling pathway. Sweet taste signaling is known 
to be mediated by heterodimeric G-protein coupled receptors and 
speciﬁ  c downstream signaling elements. More precisely, the trans-
duction of sweet tastants is mediated by the taste genes Tas1r2 
and Tas1r3 (Bachmanov and Beauchamp, 2007), whose T1R2 and 
T1R3 products assemble to form the heterodimeric sweet receptor 
T1R2/T1R3 (Nelson et al., 2001; Zhang et al., 2003; Zhao et al., 
2003). A similar mechanism mediates the recognition of l-amino 
acids via the Tas1r1 and Tas1r3 genes (Bachmanov and Beauchamp, 
2007; Nelson et al., 2002). T1R2/T1R3 and T1R1/T1R3 receptor 
signaling are at least in part supported by the taste-speciﬁ  c heterot-
rimeric G-protein gustducin, formed by α-gustducin (McLaughlin 
et al., 1992), Gβ3 and Gγ13 (Huang et al., 1999). Because the sweet 
receptor T1R2/T1R3 is also expressed in the gastrointestinal tract 
(Bezencon et al., 2007), where it plays important physiological roles 
by mediating hormonal responses to the presence of tastants in the 
lumen (Margolskee et al., 2007), we hypothesized that sweet taste-
related signaling molecules might also be involved in responses to 
extracellular levels of brain glucose in a way that is independent 
from its intracellular metabolic processing.
MATERIALS AND METHODS
AMPLIFICATION AND SEQUENCING OF TASTE GENES 
FROM MOUSE BRAIN cDNA
Total RNAs were extracted from mouse or rat brain tissue using the 
TRIzol reagent (Invitrogen), puriﬁ  ed by Acid-Phenol:Chloroform 
(Applied Biosystems) and reverse-transcribed into cDNA using 
SuperScriptII (Invitrogen) according to the manufacturer’s instruc-
tions. The cDNA (equivalent to 200 ng RNA) was ampliﬁ  ed by 
real-time (RT)-PCR using an ABIPRISM 7900HT sequence detec-
tion system (Applied Biosystems). Taqman primers and probes 
for the following genes were purchased from Applied Biosystems 
(Mm99999915_g1 for GAPDH, Mm00516381_m1 for Gnb3, 
Mm00458152_ml for Gng13. The assay IDs for Gnat3, Tas1r1, Tas1r2 
and Tas1r3 are listed in Table 1). The cycling conditions were 1 cycle 
at 50°C for 2 min, 1 cycle at 95°C for 10 min, followed by 50 cycles 
at 95°C for 15 s and 60°C for 1 min. GAPDH primers were used 
as internal controls. To conﬁ  rm the speciﬁ  city of the products and 
rule out genomic contamination in the RT-PCR assay, the products 
of Gnat3, and Tas1r1, Tas1r2 and Tas1r3 from mouse cortex were 
puriﬁ  ed using the QIAquick PCR Puriﬁ  cation Kit (Qiagen), ligated 
into the pDrive cloning vector with the QIAGEN PCR Cloning Kit 
(Qiagen) and sequenced (the presence of Gnb3 and Gng13 had been 
shown in brain previously, Huang et al., 1999). Multiple sequence 
alignment was performed on the sequenced ampliﬁ  ed segments 
using the CLUSTAL W (V. 1.8) software.
RELATIVE QUANTIFICATION OF GENE EXPRESSION LEVELS 
FROM REAL-TIME PCR DATA
Relative gene expression levels across regions and/or conditions 
were computed using the 2
−Δ Δ CT method as described previously 
(Livak and Schmittgen, 2001). In all experiments, GAPDH was used 
as an internal reference in order to control for variations in cDNA 
concentration across samples. Brieﬂ  y, given a speciﬁ  c sample and a 
target gene of interest, the quantity ΔCT = (CT, Target − CT, GAPDH) was 
computed, where CT, Target and CT, GAPDH correspond to the detected 
threshold cycles for the target gene and GAPDH, respectively, for 
Table 1 | Details on taste gene ampliﬁ  cation from brain tissue.
Gene  ABI assay ID  Refseq  Amplicon length (bp)  Cloned sequence
Gnat3  Mm01165313_m1 NM_001081143.1 65  TGCACCTCAGCATTTGCTTTCCAGAATATACTGGACCA
       AACACATTTGAAGATGCAGGGAACTAC
Tas1r1 Mm00473433_m1  NM_031867 .1  79  CTGACTGTCTGCAGGTGAGACACAGACCTCTGGTGAC
       AAGTTGTGACAGGTCTGACAGCTTCAACGGCCATGGCTATCA
Tas1r2 Mm00499716_m1  NM_031873.1  83  CGAGGCTGACCTACATTAGCAATGTGTCCTGGTACACC
       CCCAACAACACGGTCCCCATATCCATGTGTTCTAAGAGTTGCCAG
Tas1r3  Mm00473459_g1 NM_031872.2  68  AGCTGCAGCAGTCTAAAATGTACTGGCCAGGCAACCA
       GGTGCCAGTCTCCCAGTGTTCCCGCCAGTGCFrontiers in Integrative Neuroscience  www.frontiersin.org  June 2009  | Volume 3  |  Article 12  |  3
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this particular sample. To compute the relative expression levels for 
a target gene across different brain regions, the quantity
ΔΔCT = (CT, Target − CT, GAPDH)R1 − (CT, Target − CT, GAPDH)R2
           = (ΔCT)R1 − (ΔCT)R2
was calculated, where R1 and R2 correspond to two different brain 
regions. Then, the relative levels of expression between regions were 
computed as 2
−ΔΔCT. The resulting values were then multiplied by 
100 and expressed as percent values, with 100% corresponding to no 
relative differences in expression levels, by deﬁ  nition, since 20 = 1. By 
analogy, the relative changes in expression levels of a target gene in a 
given brain region due to a certain experimental manipulation (e.g., 
food-deprived vs. fed animals) was computed via the quantity
ΔΔCT = (CT, Target − CT, GAPDH)C1 − (CT, Target − CT, GAPDH)C2
           = (ΔCT)C1 − (ΔCT)C2
where C1 and C2 correspond to two different experimental condi-
tions. By analogy, the relative changes in expression levels in a given 
brain region to speciﬁ  c experimental manipulation were computed 
as 2
−ΔΔCT.
One important assumption of the 2
−ΔΔCT method concerns the 
insensitivity of the internal control reference gene to experimental 
treatment. Table 2 displays the CT values for GAPDH for all experi-
mental conditions reported in this study, including GAPDH CT 
values associated with the different brain regions analyzed. In each 
case, appropriate statistical tests were performed to ascertain that 
GAPDH levels did not vary due to our experimental treatments 
and/or depend on brain region analyzed.
Finally, the option for 2
−ΔΔCT, a relative expression method, rather 
than for an absolute quantiﬁ  cation approach is based on the fact 
that no hypotheses concerning the effects of our experimental 
treatments on the amount of genes have been formulated a priori. 
While we considered relevant to determine whether gene levels were 
up- or downregulated according to experimental conditions such 
as changes in nutritional state, we assumed that such analysis does 
not require the quantiﬁ  cation of absolute gene copy numbers. This 
is consistent with the principle that absolute quantiﬁ  cation should 
be restricted to situations where it is necessary to determine the 
absolute transcript copy numbers (Livak and Schmittgen, 2001).
IN SITU HYBRIDIZATION
In situ hybridization (ISH) was performed using radiolabeled ribo-
probes according to conventional protocols with minor modiﬁ  -
cations (Newton et al., 2002). The reverse primer included a T7 
template sequence (TAATACGACTCACTATAGGGAGA) on the 
5’end while the forward primer included a Sp6 template sequence 
(ATTTAGGTGACACTATAGAA). For Tas1r2, PCR product was 
generated by PCR using gene-speciﬁ  c primers, forward-ccacac-
cctccacagactcc; reverse-ccacacactcgaagcagcac. For Gnat3, primers 
were forward-cgtgccaaatgagcaagatg; reverse-tctggaaagcaaatgct-
gagg and for Tas1r3 primers were forward-acggtgtgacgacatcatgc, 
reverse-ggtgtagggctctgccacac. Mouse hippocampal cDNA was 
used as the template for PCR, which was performed in a RT-PCR 
instrument (SmartCycler; Cepheid, Sunnyvale, CA, USA) using 
the Quantitect Sybr Green PCR Kit (Qiagen). PCR product was 
puriﬁ  ed by ethanol precipitation and was resuspended in TE buffer. 
One microgram of each PCR product was used to produce radiola-
beled riboprobes using a T7 or Sp6-based in vitro transcription kit 
(Maxiscript, Ambion). Sp6 transcription was used to generate the 
sense Tas1r2 probe while T7 transcription was used to produce the 
sense probe. Speciﬁ  city of the PCR product was veriﬁ  ed by sequenc-
ing. Radiolabeled CTP was included in the in vitro transcription 
reaction and 2 million counts were added to each slide. Sections 
Table 2 | CT values for GAPDH under the different experimental conditions.
Experimental condition  GAPDH CTs (mean ± SEM)  Statistical comparison  Does GAPDH vary signiﬁ  cantly?
Comparison across  Hypothalamus = 18.04 ± 0.44  One-way ANOVA across regions  No
brain regions  Cortex = 17 .02 ± 1.0   
  Hippocampus = 17 .24 ± 0.75    p = 0.62
Fed × hungry  Fed hypothalamus = 17 .52 ± 1.32  Two-sample t-tests No
  Fed cortex = 16.28 ± 0.21  Fed × hungry in hypothalamus and   p = 0.16
  Fed hypothalamus = 16.64 ± 0.25  cortex (see “Results”)  p = 0.37
  Fed cortex = 16.01 ± 0.18    df = 4
Obese × lean  Obese hypothalamus = 18.7 ± 0.29  Two-sample t-tests No
  Obese cortex = 17 .46 ± 0.17  Obese × lean in hypothalamus and   p = 0.83
  Lean hypothalamus = 18.87 ± 0.56  cortex (see “Results”)  p = 0.85
  Lean cortex = 17 .38 ± 0.87    df = 4
Glucose level in cell  0.1 mM = 15.25 ± 0.22  One-way ANOVA across glucose  No
culture medium  0.5 mM = 15.23 ± 0.20  concentrations 
  1.5 mM = 15.28 ± 0.23    p = 0.99
  2.5 mM = 15.33 ± 0.24   
  5.0 mM = 15.38 ± 0.27   
  10.0 mM = 15.42 ± 0.31   
Adding sucralose to cell  0.5 mM glucose = 17 .36 ± 0.18  Two-sample t-test No
culture medium  0.5 mM glucose + 0.5 mM  0.5 mM glucose × 0.5 mM  p = 0.26
  sucralose = 16.86 ± 0.33  glucose + 0.5 mM sucralose  df = 4Frontiers in Integrative Neuroscience  www.frontiersin.org  June 2009  | Volume 3  |  Article 12  |  4
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were opposed to autoradiographic ﬁ  lm (Kodak BioMax MR ﬁ  lm, 
Cat# 870 1302) and developed in an automated developer. ISH 
images were captured using a digital camera (Scion Corporation) 
and visualized using NIH Image J software. Speciﬁ  city of probes 
were tested by verifying that anti-sense probes produced no sig-
niﬁ  cant hybridizations to brain tissue (results shown in Figure 1 
in Supplementary Material).
IMMUNOHISTOCHEMISTRY
Mice were anesthetized with 5% isoﬂ  urane, injected with a lethal 
dose of Euthasol (0.1 ml i.p.) and cardio-perfused with PBS fol-
lowed by 4% paraformaldehyde (PFA) in PBS. Brains were removed, 
postﬁ  xed in 4% PFA overnight. All brains were cryoprotected in 
30% sucrose in PBS. Thirty micrometer sections were cut using 
a cryostat. For DAB staining, ﬂ  oating sections were pretreated 
for 1 h in PBS containing 0.3% H2O2 to eliminate endogenous 
peroxidase activity, incubated overnight with rabbit anti-T1R2, 
or goat anti-T1R3 (1:50, Santa Cruz Biotechnology and Abcam) 
in 3% normal donkey serum (NDS) in PBS containing 0.25% 
Triton X-100 (PBST), and then incubated for 1  h with bioti-
nylated donkey anti-rabbit IgG or anti-goat IgG antibody (1:500, 
Vector Laboratories) followed by ABC solution (Vectastain ABC 
elite kit, Vector Laboratories). Signals were visualized in PBS con-
taining 0.02% 3,3′-diaminobenzidine-4HCl, and 0.001% H2O2. 
For immunoﬂ  uorescent labeling, brain sections were incubated 
overnight with both rabbit anti-α-gustducin (1:100, Santa Cruz, 
sc-395) and mouse anti-Neun (1:100, Millipore), and then incu-
bated with Alexa-594 donkey anti-rabbit IgG for 1 h, followed by 
Alexa-488 donkey anti-mouse IgG for 1 h (Invitrogen), and ﬁ  nally 
mounted on slides using Vectashield anti-fade (Vector Laboratories, 
CA, USA). Fluorescence images were obtained using a confocal 
microscope (Fluoview F1000, Olympus).
IN VIVO STUDIES
Adult male mice with a C57BL/6 background were used. At the 
time of experiments animals were 3–6 months old. Leptin-deﬁ  cient 
ob/ob mice and their lean wild-type counterparts were obtained 
from the Jackson Laboratory (Bar Harbor, ME, USA). For the 
food-deprivation study, 10 wild-type single-housed animals were 
either selected to be food-deprived for 24 h (water access only) 
or to remain under ad libitum chow and water access. After this 
period, animals were anesthetized with an overdose of Euthasol 
(0.1 ml i.p.) and brains were quickly removed, selected brain areas 
were dissected and samples were immediately sonicated and treated 
for total RNA extraction as explained above. For experiments with 
obese hyperglycemic ob/ob animals, procedures were as above, with 
the exception that all animals in this case were maintained at ad 
libitum conditions. Glucose levels were determined by using a hand-
held glucometer (OneTouch) following overnight fasting. All pro-
cedures were approved by The J. B. Pierce Laboratory Animal Care 
and Use Committee.
EMBRYONIC MOUSE HYPOTHALAMIC CELL LINE
Plates containing the Embryonic Mouse Hypothalamic Cell Line 
N38 (Cellutions Biosystems Inc.) was grown in 1 × DMEM (high 
glucose, Invitrogen) with 10% fetal bovine serum, and 1% peni-
cillin/streptomycin and maintained at 37°C under 5% CO2. For 
the glucose-sensing experiments, the cells were washed with PBS 
and cultured in a no glucose DMEM medium (Invitrogen), to 
which was added either one of 0.1, 0.5, 1.5, 2.5, 5 and 10 mM 
glucose (Sigma-Aldrich) or 0.5 mM glucose + 0.5 mM sucralose 
(USP), for 45 min before RNA extraction. All the other procedures 
including ampliﬁ  cation and analysis of RT quantitative PCR data 
were as above. To conﬁ  rm the speciﬁ  city of and rule out genomic 
contamination on the RT-PCR assay, the products of Gnat3, 
and Tas1r1, Tas1r2 and Tas1r3 from mouse cortex were puri-
ﬁ  ed using the QIAquick PCR Puriﬁ  cation Kit (Qiagen), ligated 
into the pDrive cloning vector with the QIAGEN PCR Cloning 
Kit (Qiagen) and sequenced. Multiple sequence alignment was 
performed on the sequenced ampliﬁ   ed segments using the 
CLUSTAL W (V. 1.8) software. For immunoﬂ  uorescence experi-
ments, plated cells were ﬁ  xed for 20 min with 4% PFA in PBS 
at room temperature, incubated overnight with goat anti-T1R3 
and either rabbit anti-α-gustducin or anti-T1R2. Cultured cells 
were then incubated with Alexa488 donkey anti-rabbit IgG for 
1 h, followed by Alexa-594 donkey anti-goat for 1 h (Invitrogen), 
and ﬁ  nally mounted on slides using Vectashield anti-fade (Vector 
Laboratories, CA, USA).
RESULTS
AMPLIFICATION AND CLONING OF TASTE GENES 
FROM MOUSE BRAIN cDNA
Gene-speciﬁ  c Taqman probes and primers (see “Materials and 
Methods” section) were used to amplify the following taste-related 
genes: Tas1r1, Tas1r2, Tas1r3, Gnat3, Gnb3 and Gng13 from mouse 
brain cDNA. The ﬁ  rst three gene products encode the subunits 
forming the heterodimeric taste receptors T1R1/T1R3 (l-amino 
acid, Nelson et al., 2002) and T1R2/T1R3 (sweet, Zhao et al., 2003), 
and the last three respectively encode the products α-gustducin, Gβ3 
and Gγ13 that form the α, β and γ subunits of heterotrimeric taste 
G-protein gustducin (Huang et al., 1999; McLaughlin et al., 1992). 
All probes were designed to amplify regions containing exon–exon 
junctions, and PCR product sizes were veriﬁ  ed by gel electrophore-
sis. To completely exclude the possibility that ampliﬁ  cation of taste 
genes resulted from genomic DNA contamination in the samples, 
PCR products for Tas1r1, Tas1r2, Tas1r3 and Gnat3 were ligated into 
pDrive cloning vectors, cloned and sequenced. Sequencing results 
revealed that the ampliﬁ  ed regions corresponded to intronless seg-
ments 100% similar to the cDNA published sequences (see Table 1 
for the actual cloned sequences and further details).
TASTE-RELATED GENES ARE HIGHLY EXPRESSED IN HYPOTHALAMUS 
COMPARED TO CORTEX AND HIPPOCAMPUS
Having established that the taste-related genes above are reliably 
expressed in the mouse brain, we proceeded to quantify the rela-
tive amounts of gene expression across different brain regions. 
We have used an RT quantitative PCR assay similar to a proce-
dure previously employed to quantify relative amounts of taste-
related gene expression in the gastro-intestinal tract (Bezencon 
et al., 2007). Relative gene expression levels across regions were 
computed using the 2
−ΔΔCT method (see “Materials and Methods” 
and Livak and Schmittgen, 2001) and were expressed as percent 
expression levels in hypothalamus relative to either cortex or hip-
pocampus. Values = 100% imply that the hypothalamus displayed Frontiers in Integrative Neuroscience  www.frontiersin.org  June 2009  | Volume 3  |  Article 12  |  5
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no relative differences in expression levels with respect to a given 
region; values > 100% imply that the hypothalamus displayed 
relatively higher levels of expression compared to a given region; 
and values < 100% imply that the hypothalamus displayed rela-
tively lower levels of expression compared to a given region (see 
“Materials and Methods” for details). Templates were obtained 
from dissected brains of seven adult male C57B6 mice, and relative 
quantiﬁ  cation was performed using a within-subject design and 
expressed as mean% levels ± SEM in hypothalamus compared to 
either cortex or hippocampus.
In the forebrain, we have primarily detected the presence of 
Tas1r1, Tas1r2, Tas1r3, Gnat3, Gnb3 and Gng13 in the hypotha-
lamus, hippocampus and cortex. Overall, we found that the 
hypothalamus displayed the highest levels of taste-related gene 
expression, followed by cortex and hippocampus. We compared 
the overall percent levels in hypothalamus (with respect to cor-
tex and hippocampus) against the baseline level of 100%. First, 
a two-way taste gene × brain region ANOVA revealed signiﬁ  cant 
main effects of taste gene (F = 10.34, df = 5, p < 0.001) and brain 
region (F = 6.92, df = 1, p < 0.02) on expression levels, with no 
signiﬁ  cant interaction effects (F = 1.04, df = 5, p = 0.4). This result 
suggests, in particular, a difference in expression levels between 
cortex and hippocampus when these regions are normalized to 
hypothalamic expression levels. Next, we analyzed expression levels 
in cortex and hippocampus, in relation to hypothalamic levels, for 
each taste gene separately. Most often, taste genes were found to 
be expressed at signiﬁ  cantly higher levels in hypothalamus com-
pared to the hippocampus and, to a lesser extent, the cortex. In fact, 
Tas1r1 was found to be signiﬁ  cantly more expressed in hypothala-
mus compared to the hippocampus (250 ± 47% of hypothalamic 
levels, one-sample t-test against 100% baseline t = 3.15, df = 6, 
p < 0.02) but only marginally higher in hypothalamus compared to 
cortex (126 ± 26%, t = 0.73, df = 6, p > 0.3, Figure 1A; red dashed 
line denotes 100% baseline level). On the other hand, Tas1r2 was 
found to be expressed at signiﬁ  cantly higher levels in hypothalamus 
compared to both cortex and   hippocampus, with relative expres-
sion levels of 121 ± 6% (t = 3.05, df = 6, p < 0.03) and 156 ± 16% 
(t = 3.41, df = 6, p < 0.02), respectively (Figure 1B). A pattern simi-
lar to Tas1r2 was observed for Tas1r3, with this receptor gene being 
expressed at signiﬁ  cantly higher levels in hypothalamus compared 
to both cortex and hippocampus, with relative expression levels of 
228 ± 45% (t = 2.8, df = 6, p < 0.02) and 505 ± 207% (one-tailed 
t = 1.95, df = 6, p < 0.05), respectively (Figure 1C). We have also 
analyzed the relative expression levels of the taste G-protein genes. 
For Gnat3, although expression levels were on average higher in 
hypothalamus compared to cortex and hippocampus, such dif-
ference did not reach signiﬁ  cance (129 ± 31%, t = 0.94, df = 6, 
p = 0.37 for cortex and 321 ± 136%, t = 1.62, df = 6, p = 0.15 for 
hippocampus, Figure 1D). The expression levels of Gnb3, on the 
other hand, were clearly higher in hypothalamus compared to 
both cortex (735 ± 104%, t = 6.09, df = 6, p < 0.001) and hippoc-
ampus (1413 ± 468%, t = 2.8, df = 6, p < 0.04, Figure 1E). Finally, 
for Gng13, expression levels in hypothalamus were only 85 ± 16% 
of those observed in cortex, a difference that nevertheless was not 
signiﬁ  cant (t = −0.84, df = 6, p = 0.43), although levels of this gene 
were signiﬁ  cantly higher in hypothalamus compared to hippocam-
pus (224 ± 49%, t = 2.5, df = 6, p < 0.05, Figure 1F).
Overall, our expression analyses revealed that the taste receptor 
Tas1r genes are highly expressed in the hypothalamus compared 
to both hippocampus and cortex (with the notable exception of 
Tas1r1). In addition, a similar pattern was observed regarding the 
associated taste G-protein genes, with the exception of Gnat3, the 
gene encoding for the G-protein α-gustducin, which appears to 
be more homogenously expressed throughout these three forebrain 
regions than the other taste genes.
TASTE-RELATED GENES ARE PREFERENTIALLY EXPRESSED IN NEURONS
We were also interested in determining the brain cell types 
more likely to express the taste-related genes. More speciﬁ  cally, 
to determine whether taste-related proteins are preferentially 
expressed in neurons compared to other cell types, we performed 
double-labeling immunoﬂ  uorescence experiments using anti-
bodies against taste-related proteins and the neuronal marker 
NeuN, a neuronal-speciﬁ  c nuclear protein in vertebrates (Mullen 
et al., 1992). Overall, based on our immunohistochemical (IHC) 
assay, we found that the expression of taste-related genes in the 
brain is predominantly neuronal. In Figures 1G–I are shown 
the results of double labeling the hippocampal area with anti-
bodies against α-gustducin and NeuN. Whereas essentially all 
α-gustducin-expressing cells were also labeled by NeuN, virtually 
none of the large number of astrocytes in this region reacted 
to the α-gustducin antibody. The same pattern was found to 
hold for the hypothalamus; the same IHC procedure applied to 
the hypothalamus revealed a very consistent overlap between 
α-  gustducin- and NeuN-labeled cells (Figures 1J–L). Similar 
patterns were observed for the other taste gene products includ-
ing T1R2 and T1R3 (not shown). However, it must be noted 
that scarce numbers of non-neuronal cells also reacted to taste 
proteins and their expression in non-neuronal tissue cannot be 
excluded based on our ﬁ  ndings.
ANATOMICAL LOCALIZATION OF TASTE-RELATED GENES AND THEIR 
PRODUCTS IN THE MOUSE BRAIN
To further explore the anatomical localization of the taste-related 
genes and their products, we performed both ISH and IHC analyses 
of taste genes and their associated protein products, respectively. 
We were especially interested in the expression of the subunits 
forming the heterodimeric sweet receptor T1R2/T1R3. Overall, 
the pattern resulting form both analyses were highly consistent. 
We have detected by ISH robust expression of Tas1r2 and Tas1r3 
in the neurons of the CA ﬁ  elds and dentate gyrus of the hippoc-
ampus (Figures 2A and 3A, respectively). An equivalent expres-
sion pattern was obtaining by IHC using two different antibodies 
against their products (see “Materials and Methods”), as shown in 
Figures 2B and 3B for T1R2 and T1R3, respectively. In addition, 
strong expression was found in the hypothalamus, in particular in 
areas surrounding the ventral part of the third ventricle as pointed 
in the overall brain section by both ISH (Figures 2C and 3C) and 
IHC (Figures 2D and 3D) for T1R2 and T1R3, respectively. Note 
that IHC allowed us to visualize in particular a population of 
putative neuroendocrine neurons in the paraventricular nucleus 
of the hypothalamus reacting to both T1R2 and T1R3 (Figures 2D 
and 3D, respectively). In addition, expression patterns were detected 
in cortex by both ISH (Figure 2E) and IHC (Figures 2F and 3F). Frontiers in Integrative Neuroscience  www.frontiersin.org  June 2009  | Volume 3  |  Article 12  |  6
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FIGURE 1 | (A–F) Relative levels of expression of taste genes in the mouse 
hypothalamus compared to cortex and hippocampus. Taste genes were found to 
be expressed at signiﬁ  cantly higher levels in the hypothalamus compared to the 
other regions found to express these genes, i.e., cortex and hippocampus. The 
panels depict the results of quantifying the relative levels of expression as 
obtained by using real-time quantitative PCR methods. Relative gene expression 
levels across regions were computed using the 2
−ΔΔCT method (see “Materials 
and Methods” and Livak and Schmittgen, 2001) and were expressed as percent 
expression levels in hypothalamus relative to either cortex or hippocampus. 
Values = 100% imply that the hypothalamus displayed no relative differences in 
expression levels with respect to a given region; values > 100% imply that the 
hypothalamus displayed relatively higher levels of expression compared to a 
given region; and values < 100% imply that the hypothalamus displayed 
relatively lower levels of expression compared to a given region (see “Materials 
and Methods” for details). (A–C) Relative levels for taste receptor-related genes 
Tas1r1, Tas1r2 and Tas1r3, respectively. (D–F) Relative levels for taste G-protein-
related genes Gnat3, Gnb3 and Gng13, respectively. Note that, overall, the 
hypothalamus displayed signiﬁ  cantly higher levels of expression compared to 
cortex and hippocampus, with the noted exception of Tas1r1 in cortex (similar 
levels in hypothalamus compared to cortex) and the G-protein gene Gnat3. See 
“Results” for details. Dashed red line depicts the 100% baseline levels. (*All 
p < 0.05, one-sample t-test against 100%). n.s.: p ≥ 0.05. (G–I) Co-expression of 
taste signaling molecules and the nuclear neuronal marker NeuN in the mouse 
hippocampus as assessed by immunoﬂ  uorescence methods. Confocal images 
(×10 magniﬁ  cation) of the mouse hippocampus labeled for α-gustducin (G) and 
NeuN (H). Strong co-expression patterns were observed (I), suggesting that 
taste-related molecules of the brain are preferentially expressed in neurons.
(J–L) The same as in (G–I), but for the case of the medial hypothalamus (×60 
magniﬁ  cation). Results were qualitatively the same in hypothalamus as in 
hippocampus.Frontiers in Integrative Neuroscience  www.frontiersin.org  June 2009  | Volume 3  |  Article 12  |  7
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FIGURE 2 | Anatomical distribution of the gene Tas1r2, and of its product, 
the taste receptor subunit T1R2. Images from the mouse hippocampus, 
hypothalamus and cortex obtained from both in situ hybridization and DAB 
immunolabeling methods were placed alongside. (A) Tas1r2 and (B) T1R2 
expression in the hippocampus. Note the strong levels of both gene and protein 
expression on the CA ﬁ  elds and dentate gyrus, further demonstrating the 
preferential expression of taste-related elements in neurons. Note also the 
proximity of the hippocampus to the lateral ventricle. (C) Overall view of a brain 
section hybridized against a Tas1r2 probe. Note the high levels of expression in 
hippocampus, periventricular, including arcuate nucleus, of the hypothalamus, 
cortex and habenula. ISH also identiﬁ  ed Tas1r2 expression in the epithelial cells 
of the choroid plexus. (D) T1R2 expression in the paraventricular nucleus of the 
hypothalamus. Note the generally higher expression levels of both gene and 
protein in proximity to the third ventricle. (E) T1R2 expression in the arcuate 
nucleus of the hypothalamus. Note the generally higher expression levels of 
both gene and protein in proximity to the third ventricle. (F) T1R2 expression in 
the cortex. Note that cortical expression seems to be restricted to layer IV of the 
cortex for both gene and protein expression. Arc, arcuate nucleus of the 
hypothalamus; Ctx, cortex; CP , choroid plexus; dLV, dorsal part of the lateral 
ventricle; d3V, dorsal part of the third ventricle; Hb, habenula; Hipp, hippocampal 
region; PVH, paraventricular nucleus of the hypothalamus; v3V, ventral part of 
the third ventricle.
Figures 2E and 3E show the results of immunolabeling against 
T1R2 and T1R3 antibodies, respectively, in the hypothalamic arcu-
ate nucleus. Finally, it must be noted that additional areas were 
found to express taste-related genes and proteins, especially areas 
of the periventricular regions around the dorsal aspect of the third 
ventricle, including the medial habenula and the epithelial cells of 
the choroid plexus (shown Figures 2A–C and 3A–B for Tas1r2/
T1R2 and Tas1r3/T1R3, respectively) as well as the paraventricular 
nucleus of the thalamus (not shown).
FOOD DEPRIVATION AND NUTRIENT EXCESS REGULATE EXPRESSION 
LEVELS OF Tas1r1 AND Tas1r2 IN HYPOTHALAMUS BUT NOT CORTEX
To assess the possible functional roles of taste-related signals in the 
brain, we have performed further RT quantitative PCR analyses on 
hypothalamic and cortical samples from ﬁ  ve mice exposed to 24-h 
food deprivation and compared the gene expression levels in these 
animals to those observed in ﬁ  ve mice that were fed ad libitum. 
We reasoned that, if taste-related signaling elements play a role in 
sensing nutrients in the brain, then their levels might be regulated Frontiers in Integrative Neuroscience  www.frontiersin.org  June 2009  | Volume 3  |  Article 12  |  8
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by the nutritional state of the animal, which will determine the 
concentration and identity of nutrients including glucose and 
amino acids that actually reach the brain. Overall, we found that 
the taste receptor genes Tas1r1 and Tas1r2 increased their levels 
of expression following food deprivation in the hypothalamus, 
but not in cortex, indicating that taste receptor-related genes are 
sensitive to nutrient levels in the brain regions regulating energy 
homeostasis. These changes in expression levels seemed to be 
speciﬁ  c to the taste receptor genes Tas1r1 and Tas1r2. In fact, 
compared to fed animals, deprived animals showed non-signiﬁ  -
cant decreases in Gnat3 in both hypothalamus (81 ± 25%, paired 
within-subject two-sample one-tailed t-test against 100% baseline, 
df = 4, t = −0.7, p > 0.7) and cortex (73 ± 26%, t = −0.1, p > 0.8, 
see Figure 4A); however, Tas1r1 levels were signiﬁ  cantly higher in 
deprived compared to fed animals in hypothalamus (164 ± 21%, 
t = 2.94, p < 0.03) but not in cortex (165 ± 35%, t = 1.84, p = 0.07, 
see Figure 4B). A similar effect was found for Tas1r2: expres-
sion levels were signiﬁ  cantly higher in deprived, compared to 
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FIGURE 3 | Anatomical distribution of the gene Tas1r3, and of its product, 
the taste receptor subunit T1R3. Images from the mouse hippocampus, 
hypothalamus and cortex obtained from both in situ hybridization and DAB 
immunolabeling methods were placed alongside. (A) Tas1r3 and (B) T1R3 
expression in the hippocampus. Note the strong levels of both gene and 
protein expression on the CA ﬁ  elds and dentate gyrus, further demonstrating 
the preferential expression of taste-related elements in neurons. Note also the 
proximity of the hippocampus to the lateral ventricle. (C) Overall view of a 
brain section hybridized against a Tas1r3 probe. Note the high levels of 
expression in hippocampus, hypothalamus, cortex and habenula. ISH also 
identiﬁ  ed Tas1r3 expression in the epithelial cells of the choroid plexus. 
(D) T1R3 expression in the hypothalamus. In (D), note the generally higher 
expression levels of both gene and protein in proximity to the third ventricle 
(PVH). (E) T1R3 expression in the arcuate nucleus of the hypothalamus as 
revealed by immunoﬂ  uorescence methods. Picture was taken using a confocal 
microscope. (F) T1R3 expression in the cortex. Note that cortical expression 
seems to be restricted to layer IV of the cortex. ARC, arcuate nucleus of the 
hypothalamus; Ctx, cortex; CP , choroid plexus; dLV, dorsal part of the lateral 
ventricle; d3V, dorsal part of the third ventricle; Hb, habenula; Hipp, 
hippocampal region; Hyp, basal aspect of the hypothalamus; PVH, 
paraventricular nucleus of the hypothalamus; v3V, ventral part of the third 
ventricle.Frontiers in Integrative Neuroscience  www.frontiersin.org  June 2009  | Volume 3  |  Article 12  |  9
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fed,  animals in hypothalamus (255 ± 64%, t = 2.41, p < 0.04) but 
not in cortex (124 ± 25%, t = 0.94, p = 0.2, see Figure 4C). Finally, 
and rather strikingly given the above, no signiﬁ  cant changes were 
observed for Tas1r3 in either hypothalamus (90 ± 7%, t = −1.14, 
p > 0.8) or cortex (99 ± 9%, t = −0.15, p > 0.5, see Figure 4D). 
These results indicate that the expression levels of the taste recep-
tor genes Tas1r1 and Tas1r2 in the hypothalamus are under the 
control of nutrient availability.
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FIGURE 4 | (A–D) Relative levels of expression of taste genes in food-deprived 
mice compared to fed mice in hypothalamus and cortex. Taste receptor-related 
genes Tas1r1 and Tas1r2 were found to be expressed at signiﬁ  cantly higher 
levels in the hypothalamus, but not cortex, of food-deprived animals when 
compared to fed animals. The panels depict the results of quantifying the relative 
levels of expression as obtained by using real-time quantitative PCR methods. 
Relative gene expression levels across regions were computed using the 2
−ΔΔCT 
method (see “Materials and Methods” and Livak and Schmittgen, 2001) and 
were expressed as percent expression levels in hypothalamus or cortex 
observed in deprived compared to fed animals. Values = 100% imply that the 
brain region displayed no relative differences in expression levels in deprived 
compared to fed animals; values > 100% imply that the brain region displayed 
relatively higher levels of expression in deprived compared to fed animals; and 
values < 100% imply that the brain region displayed relatively lower levels of 
expression in deprived compared to fed animals (see “Materials and Methods” 
for details). (A–D) Relative levels for taste receptor-related genes Gnat3, Tas1r1, 
Tas1r2 and Tas1r3, respectively. Note signiﬁ  cant changes in Tas1r1 and Tas1r2 
levels. (E–F) Taste receptor-related genes Tas1r1 and Tas1r2 were found to be 
expressed at signiﬁ  cantly higher levels the hypothalamus, but not cortex, of lean 
animals when compared to obese, hyperglycemic ob/ob mice. Data are 
expressed as percent levels of expression in the deprived animals compared to 
the fed animals, with 100% representing baseline (no relative change) levels. 
Panels show relative levels for taste receptor-related genes Tas1r1 (E) and 
Tas1r2 (F). The other genes did not show signiﬁ  cant changes in expression 
levels. (*All p < 0.05, one-sample t-test against 100%). Dashed red line depicts 
the 100% baseline levels.Frontiers in Integrative Neuroscience  www.frontiersin.org  June 2009  | Volume 3  |  Article 12  |  10
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We next asked the question of whether, conversely, abnormally 
high levels of circulating nutrients could induce a relative decrease 
in expression levels in hyperglycemic compared to euglycemic mice. 
We have therefore compared the taste gene expression levels in 
hypothalamus and cortex between obese hyperglycemic ob/ob 
mice (n = 5) and wild-type lean controls (n = 5). Hyperglycemia 
in ob/ob was conﬁ  rmed by measuring blood glucose levels with 
glucometer (lean: 199  ± 28 mg/dL;  obese:  440 ± 58 mg/dL, 
p < 0.02). Based on the results above, we hypothesized that Tas1r 
genes would be expressed at higher levels in the hypothalamus, 
but not cortex, of lean compared to obese mice. In fact, a direct 
comparison between Tas1r expression levels between lean and obese 
animals reveal that lean mice displayed signiﬁ  cantly higher levels 
of expression in hypothalamus (205 ± 53%, paired within-subject 
two- sample  one-tailed  t-test against 100%, t = 1.94, p < 0.04) but 
not in cortex (192 ± 54%, t = 1.69, p = 0.056), although one must 
note that results from cortex were close to reach signiﬁ  cant levels. 
In any event, once again the main contributors to this result were 
Tas1r1 (221 ± 38% in hypothalamus vs. 345 ± 143% in cortex, see 
Figure 4E) and Tas1r2 (269 ± 58% in hypothalamus vs. 107 ± 41% 
in cortex, see Figure 4F). Overall, the results from our in vivo experi-
ments indicate that the expression levels of the taste receptor genes 
Tas1r1 and Tas1r2 in the mouse hypothalamus, but not cortex, 
reﬂ  ect the current nutritional state of the animal.
GLUCOSE AND SUCRALOSE SPECIFICALLY MODULATE Tas1r2 
EXPRESSION LEVELS IN A MOUSE HYPOTHALAMIC CELL LINE
It could be argued, however, that the patterns described above result 
from systemic effects related to prolonged food deprivation or obes-
ity, rather than nutrient sensing per se. In fact, one must consider the 
possibility that systemic factors such as changes in insulin and/or 
stress hormone levels drive expression levels of taste-related genes 
in the brain. Therefore, to ascertain that gene levels were primarily 
under the control of extracellular levels of nutrients, we adopted as 
an additional experimental model an embryonic mouse hypotha-
lamic cell line (see “Materials and Methods”). We reasoned that, 
if the levels of expression of taste-related genes are controlled by 
extracellular availability of nutrients independently of systemic 
or metabolic factors, then manipulating the levels of nutrients in 
the medium should sufﬁ  ce to speciﬁ  cally alter taste gene levels in 
these dissociated cells. In particular, we hypothesized that impos-
ing physiological changes in glucose levels to the medium while 
maintaining other nutrient levels unaltered should speciﬁ  cally alter 
expression levels of Tas1r2, the sweet-speciﬁ  c gene, while leaving 
the levels of the other Tas1rs unaltered.
Before running the hypothalamic cell culture experiments we 
ascertained the plausibility of this model by verifying that these 
cells endogenously express taste-receptor genes. Likewise the case of 
our fresh brain samples, gene-speciﬁ  c Taqman probes and primers 
(see “Materials and Methods”) were used to amplify the following 
taste-related genes: Tas1r1, Tas1r2, Tas1r3, Gnat3, Gnb3 and Gng13 
from cultured hypothalamic cells cDNA. As explained above, all 
probes were designed to amplify regions containing exon–exon 
junctions, and PCR product sizes were veriﬁ  ed by gel electrophore-
sis. To completely exclude the possibility of genomic DNA con-
tamination in the samples, PCR products for Tas1r1, Tas1r2, Tas1r3 
and Gnat3 were ligated into pDrive cloning vectors, cloned and 
sequenced. Sequencing results revealed that the ampliﬁ  ed regions 
corresponded to intronless segments 100% similar to cDNA, and 
100% similar to the sequences cloned from adult mouse brains as 
described above (see Table 1 for the actual cloned sequences). These 
ﬁ  ndings were corroborated by probing plated cells with T1R2 and 
T1R3 antibodies (Figures 5A,B) and verifying their co-expression 
(Figure 5C). The same procedure was adopted using antibodies 
against α-gustducin and T1R2 or T1R3 (not shown).
We then proceeded to assess changes in gene expression levels as 
a function of glucose concentration in the medium. Speciﬁ  cally, we 
have quantiﬁ  ed the expression levels of taste genes in hypothalamic 
cells exposed to different concentrations of glucose in the culture 
medium. We assured that these manipulations in glucose levels 
were physiologically signiﬁ  cant by using concentrations of extra-
cellular glucose close to those found in the rodent hypothalamus 
during hypo-, eu- and hyperglycemic states (de Vries et al., 2003). 
More precisely, we have compared the expression levels of taste 
genes in hypothalamic cells exposed to a severely hypoglycemic 
(0.1 mM) medium to those observed in cells exposed to higher glu-
cose levels including eu- and hyperglycemic concentrations (from 
0.5 up to 10 mM). Importantly, during these experiments only 
glucose levels were manipulated, whereas levels of other nutrients 
including l-amino acids remained unaltered. We have therefore 
hypothesized that increasing glucose levels in the culture medium 
would produce a signiﬁ  cant reduction in the expression levels of 
the sweet-speciﬁ  c gene Tas1r2, but not of the other receptor genes, 
in cultured hypothalamic cells. Consistent with our hypothesis, 
hypothalamic cells exposed to a 0.5 mM medium expressed sig-
niﬁ  cantly lower levels of Tas1r2 compared to those exposed to the 
0.1 mM medium (157 ± 21% relative decrease in expression with 
0.5 mM medium compared to 0.1 mM medium, one-tailed one-
sample t-test against 100%, t = 2.68, df = 4, p < 0.05), whereas no 
signiﬁ  cant changes were observed for Tas1r1 or Tas1r3 (103 ± 6%, 
t = 0.56, df = 4, p = 0.3 and 116 ± 13%, t = 1.19, df = 4, p = 0.14, 
respectively, see Figure 5D). For G-protein gene levels, except 
for a slight but robust decrease in Gnb3 levels, no other changes 
were detected (for Gnat3, Gnb3 and Gng13, 106 ± 4%, t = 1.46, 
df = 4, p = 0.1; 113 ± 4%, t = 2.91, df = 4, p < 0.03 and 113 ± 10%, 
t = 1.29, df = 4, p = 0.13, respectively, not shown).
A similar pattern holds for the other glucose concentrations used. 
In fact, hypothalamic cells exposed to a 1.5 mM medium expressed 
signiﬁ  cantly lower levels of Tas1r2 compared to those exposed to the 
0.1 mM medium (161 ± 23%, t = 2.61, df = 4, p < 0.03), whereas no 
signiﬁ  cant changes were observed for Tas1r1 or Tas1r3 (99 ± 6%, 
t = −0.1, df = 4, p = 0.54 and 132 ± 17%, t = 1.81, df = 4, p = 0.07, 
respectively, see Figure 5E). No changes were associated in this 
case with the G-protein gene levels (for Gnat3, Gnb3 and Gng13, 
96 ± 6%,  t = −0.56,  df = 4,  p = 0.69;  112 ± 12%,  t = 1.0,  df = 4, 
p = 0.18  and  108 ± 8%,  t = 1.03,  df = 4,  p = 0.17,  respectively, 
not shown). Similarly, hypothalamic cells exposed to a 2.5 mM 
medium expressed signiﬁ  cantly lower levels of Tas1r2 compared to 
those exposed to the 0.1 mM medium (162 ± 21%, t = 2.91, df = 4, 
p < 0.03), whereas no signiﬁ  cant changes were observed for Tas1r1 
or Tas1r3 (125 ± 18%, t = 1.39, df = 4, p = 0.11 and 187 ± 54%, 
t = 1.59, df = 4, p = 0.09, respectively, see Figure 5F). No changes 
were associated in this case with the G-protein gene levels (for 
Gnat3,  Gnb3 and Gng13, 126  ± 19%,  t = 1.32,  df = 4,  p = 0.12; Frontiers in Integrative Neuroscience  www.frontiersin.org  June 2009  | Volume 3  |  Article 12  |  11
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FIGURE 5 | (A–C) Co-expression of taste signaling molecules in the 
embryonic mouse hypothalamic cell line N38 as assessed by 
immunoﬂ  uorescence methods. Confocal images (×10 magniﬁ  cation) of N38 
cells that we determine endogenously express taste-related molecules. 
(A) Expression of the receptor subunit T1R2; (B) expression of the receptor 
subunit T1R3; (C) merging, showing that these cells express both subunits of 
the sweet receptor T1R2/T1R3. (D–E) Relative decrease in the levels of 
expression of the sweet-speciﬁ  c receptor gene Tas1r2 in cultured N38 cells 
as a function of glucose levels in culture medium. The sweet receptor-speciﬁ  c 
gene Tas1r2, but not others, was found to be expressed at signiﬁ  cantly higher 
levels in N38 cells exposed to a low-glucose medium (0.1 mM) compared to 
cells exposed to higher glucose levels. The panels depict the results of 
quantifying the relative levels of expression as obtained by using real-time 
quantitative PCR methods. Relative gene expression levels across regions 
were computed using the 2
−ΔΔCT method (see “Materials and Methods” and 
Livak and Schmittgen, 2001) and were expressed as percent decrease in 
expression levels in cells exposed to a medium containing from 0.5 up to 
10 mM glucose compared to cells exposed to a medium containing 0.1 mM 
glucose. Values = 100% imply that no relative differences in expression levels 
were detected in cells exposed to a medium containing higher glucose levels 
(0.5–10 mM) compared to cells exposed to a medium containing 0.1 mM 
glucose; values < 100% imply that signiﬁ  cant decreases in expression levels 
were detected in cells exposed to a medium containing higher glucose levels 
compared to cells exposed to a medium containing 0.1 mM glucose. 
(D) Decrease in taste receptor levels produced by increasing glucose medium 
from 0.1 to 0.5 mM glucose. (E) Decrease in taste receptor levels produced 
by increasing glucose medium from 0.1 to 1.5 mM glucose. (F) Decrease in 
taste receptor levels produced by increasing glucose medium from 0.1 to 
2.5 mM glucose. (G) Decrease in taste receptor levels produced by 
increasing glucose medium from 0.1 to 5 mM glucose. (H) Decrease in taste 
receptor levels produced by increasing glucose medium from 0.1 to 10 mM 
glucose. (I) Decrease in Tas1r2 levels produced by adding 0.5 mM sucralose 
to 0.5 mM glucose. Values = 100% imply that no relative differences in 
expression levels were detected in cells exposed to a medium containing 
0.5 mM glucose + 0.5 mM sucralose compared to cells exposed to a medium 
containing 0.5 mM glucose; values < 100% imply that signiﬁ  cant decreases 
in expression levels were detected in cells exposed to a medium containing 
0.5-mM glucose + 0.5 mM sucralose compared to cells exposed to a medium 
containing 0.5 mM glucose. Dashed red line depicts the 100% baseline 
levels. (*All p < 0.05, one-sample t-test against 100%). n.s.: p ≥ 0.05.Frontiers in Integrative Neuroscience  www.frontiersin.org  June 2009  | Volume 3  |  Article 12  |  12
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151 ± 31%, t = 1.63, df = 4, p = 0.08 and 124 ± 18%, t = 1.3, df = 4, 
p = 0.13, respectively, not shown).
The above was still the case for hypothalamic cells exposed 
to hyperglycemic media. In fact, hypothalamic cells exposed to 
a 5.0 mM medium expressed signiﬁ  cantly lower levels of Tas1r2 
compared to those exposed to the 0.1 mM medium (167 ± 15%, 
t = 4.49, df = 4, p < 0.006), whereas no signiﬁ  cant changes were 
observed for Tas1r1 or Tas1r3, despite the large variance asso-
ciated with this gene (102 ± 8%, t = 0.28, df = 4, p = 0.39 and 
509 ± 375%, t = 1.08, df = 4, p = 0.16, respectively, see Figure 5G). 
No changes were associated, once again, with the G-protein gene 
levels (for Gnat3, Gnb3 and Gng13, 103 ± 2%, t = 1.18, df = 4, 
p = 0.14;  116 ± 10%,  t = 1.57,  df = 4,  p = 0.09  and  104 ± 7%, 
t = 0.67, df = 4, p = 0.26, respectively, not shown). Finally, hypoth-
alamic cells exposed to a 10.0 mM medium expressed signiﬁ  cantly 
lower levels of Tas1r2 compared to those exposed to the 0.1 mM 
medium (227 ± 31%, t = 4.0, df = 4, p < 0.009), whereas no sig-
niﬁ  cant changes were observed for Tas1r1 or Tas1r3 (107 ± 4%, 
t = 1.64, df = 4, p = 0.08 and 128 ± 15%, t = 1.88, df = 4, p = 0.06, 
respectively, see Figure 5H). No changes were associated, once 
more, with the G-protein gene levels (for Gnat3, Gnb3 and Gng13, 
109 ± 5%, t = 1.65, df = 4, p = 0.08; 124 ± 18%, t = 1.29, df = 4, 
p = 0.13 and 112 ± 7%, t = 1.54, df = 4, p = 0.09, respectively, not 
shown).
It is noticeable from the above results that hypothalamic cells 
exposed to the hyperglycemic media (5 and 10  mM) seem to 
express considerably greater decreases in Tas1r2 levels compared 
to cells exposed to the 1.5 and 2.5 mM euglycemic media (all 
comparisons with respect to the baseline 0.1 mM medium). In 
fact, based on the data described in the previous section regard-
ing the comparison between hyperglycemic ob/ob mice and their 
euglycemic counterparts, one should expect that hypothalamic 
cells exposed to hyperglycemic media should express consider-
ably greater decreases (with respect to the 0.1 mM medium) in 
Tas1r2 levels compared to the cells exposed to euglycemic media. In 
accordance with our hypothesis, a direct comparison between the 
two conditions revealed that cells exposed to hyperglycemic media 
expressed signiﬁ  cantly greater decreases in Tas1r2 levels compared 
to cells exposed to euglycemic media (197 ± 19% vs. 161 ± 14%, 
respectively, one-tailed two-sample t = 1.86,  df = 9,  p < 0.05). 
Therefore, although the Tas1r2 levels do not seem to change in 
strict accordance with ﬂ  uctuations in extracellular glucose con-
centrations, this receptor gene does function as a sensor whose 
expression levels change according to whether glucose levels deviate 
from euglycemic concentrations, an observation that is consistent 
with our in vivo studies presented above using ob/ob mice.
We then reasoned that, if sweet taste-like signaling mechanisms 
do in fact function as monitors of extracellular levels independently 
of either systemic or intracellular, GK-mediated mechanisms, then 
adding the non-metabolizable artiﬁ  cial sweetener sucralose to the 
medium should produce speciﬁ  c decreases in Tas1r2, but not Tas1r1 
or Tas1r3, levels. In fact, a one-way ANOVA performed on the per-
cent change data associated with adding sucralose to the 0.5 mM 
medium revealed a signiﬁ  cant main effect of gene (p < 0.04) on the 
relative changes in gene expression level. Conforming to our initial 
hypothesis, the larger decreases in gene expression levels produced 
by adding sucralose to the hypoglycemic medium were observed 
for the sweet-speciﬁ  c gene Tas1r2 (288 ± 89% of baseline levels), 
compared to no changes for the l-amino acid speciﬁ  c gene Tas1r1 
(99 ± 16%) or Tas1r3 (113 ± 25%, Figure 5I). No detectable changes 
in expression were found for taste G-protein-related genes (Gnat3 
106 ± 18%, Gng13 105 ± 12% and Gnb3 137 ± 25%, not shown), 
although the relatively larger although non-statistically signiﬁ  -
cant change in Gnb3 might indicate a possible speciﬁ  c role of this 
G-protein in sweet taste.
In conclusion, our experiments with cultured cells provide 
evidence in favor of a functional role for neuron-expressed sweet 
taste receptors, supporting the more general proposal that neuro-
nal cells can monitor changes in extracellular levels of glucose via 
sweet taste signaling pathways that are independent of intracellular 
metabolic events.
DISCUSSION
Based on the results of the present study, we propose that the brain 
makes use of nutrient-sensing mechanisms analogous to those 
known to operate in the periphery, i.e., via G-protein coupled taste 
receptors and their downstream signaling molecules. More spe-
ciﬁ  cally, we have demonstrated that neurons located in different 
forebrain regions, including the hypothalamus, the hippocampus, 
the cortex and the habenula, express the genes Tas1r1, Tas1r2 and 
Tas1r3, that in turn encode for the subunits of the heterodimeric 
G-  protein coupled nutrient-sensing taste receptors T1R1/T1R3 
(l-amino acids) and T1R2/T1R3 (sweet, Zhao et al., 2003). In addi-
tion, the genes encoding for the subunits of the taste-speciﬁ  c heterot-
rimeric G-protein gustducin, formed by α-gustducin (McLaughlin 
et al., 1992), Gβ3 and Gγ13 (Huang et al., 1999), were also found 
to be expressed in these same brain regions. ISH and IHC analyses 
revealed a high degree of anatomical overlap between these taste-
related genes, strongly suggesting that taste-like signaling mecha-
nisms might be capable of effectively inﬂ  uence neuronal activity. 
Furthermore, we also provide the ﬁ  rst supporting evidence that the 
levels of expression of taste-related genes are under the control of 
the nutritional state of animal, since we found that food deprivation 
and hyperglycemia induced signiﬁ  cant changes in expression levels 
of the Tas1r1 and Tas1r2 genes in the hypothalamus. Finally, the fact 
that changes in expression levels as a function of nutritional state 
were restricted to the hypothalamus in turn suggests that taste-like 
signaling mechanisms in the brain might be involved in the central 
regulation of homeostatic processes.
Different lines of evidence support the notion that taste signal-
ing molecules might function as chemosensors in different physi-
ological settings. In fact, seminal work by Hofer, Drenckhahn and 
colleagues provided the ﬁ  rst line of evidence that taste-like signaling 
mechanisms might be used by the gastrointestinal tract to sense 
the presence of nutrients in the lumen (e.g., Hofer et al., 1996). 
They have extended their ﬁ  ndings to show that taste mechanisms 
might also be involved in more general endocrine functions via 
their expression in the pancreas (Höfer and Drenckhahn, 1998). 
Early indication that such taste mechanisms play important 
physiological functions came with the discovery by Rozengurt 
and colleagues that the taste G-protein α-gustducin is expressed 
in PYY- and GLP-1-producing L cells of the intestine (Rozengurt 
and Sternini, 2007; Rozengurt et al., 2006). More recently, it has 
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the intestinal mucosa, including the sweet receptor T1R2/T1R3 
(Bezencon et al., 2007), where it plays important physiological roles 
by mediating hormonal responses to the presence of tastants in 
the lumen (Margolskee et al., 2007). Of particular interest to our 
case is the fact that transcript levels of Tas1r2 are strongly reduced 
following jejunal glucose perfusion in mice (Young et al., 2009), a 
result that closely reﬂ  ects our own ﬁ  ndings in hypothalamus (see 
below). More generally, we propose that an analogous phenomenon 
to those observed in the gut takes place with respect to neuronal 
glucosensing, with similar chemosensory mechanisms acting as 
glucose receptors in disparate physiological settings.
The principle that taste-like signaling mechanisms might play 
functional roles in the central nervous system also has its prec-
edents. For example, it has been shown that the tongue-expressed 
PKD2L1, a polycystic-kidney-disease-like ion channel and can-
didate mammalian sour taste sensor, is also expressed in speciﬁ  c 
neurons surrounding the central canal of the spinal cord (Huang 
et al., 2006). More speciﬁ  cally, it has been demonstrated that the 
PKD2L1-expressing neurons send terminals to the central canal and 
trigger action potentials in response to decreases in extracellular 
pH (Huang et al., 2006).
Among all brain regions, one would expect that nutrient- sensing 
taste receptors must be found primarily in the hypothalamus, the 
master brain circuit controlling body homeostasis (Elmquist et al., 
1999). In fact, our RT quantitative PCR expression data shows that 
the hypothalamus expresses signiﬁ  cantly higher levels of taste-
related genes compared to the cortex or hippocampus. Of particu-
lar interest was the expression of taste receptors in hypothalamic 
regions surrounding the ventral aspect of the third ventricle. This 
privileged anatomical location allows neurons to have proximal 
access to the contents of the cerebrospinal ﬂ  uid and to modulate 
their responses accordingly. In this regard, it is of interest that T1R2 
and T1R3 signals were strongly expressed in the paraventricular 
nucleus of the hypothalamus, a brain region fundamentally impli-
cated in counter-regulatory responses to hypoglycemia. One inter-
esting topic for future investigation concerns the possibility that 
paraventricular neurons expressing corticotrophin releasing factor 
(CRF), a secretagogue factor whose liberation by paraventricular 
neurons eventually results in adrenal discharge via actions on the 
anterior pituitary (Porterﬁ  eld and White, 2007), express sweet taste 
receptors. CRF release is a fundamental response to deviations from 
normal glucose levels (McCrimmon, 2008), and the presence of 
T1R2 and T1R3 in paraventricular regions known to contain CRF-
producing neurons is suggestive of chemosensory functions in this 
region. Of particular interest will be the testing of the hypothesis 
that T1R2 knockout mice display abnormal counter-regulatory 
responses to hypoglycemia due to impaired glucosensing abilities 
in CRF neurons.
The expression of taste sensors in the hippocampus, on the other 
hand, is seemingly less likely to have been anticipated. However, it 
must be noted that several molecular studies demonstrated that 
the hippocampus is a primary target for ligands that reﬂ  ect body 
physiology, including ion balance (calcium, magnesium), insu-
lin, immunity response elements, as well as reproductive, satiety 
and stress hormones (reviewed in Lathe, 2001). This argues that 
a primary, more fundamental role for the hippocampus refers 
to sensing soluble molecules present in blood and cerebrospinal 
ﬂ  uid (Lathe, 2001). We propose that the currently known list of 
chemosensory functions of the hippocampus must be expanded 
to include nutrient sensing. The idea that hippocampal neurons 
have the ability to sense extracellular levels of nutrients is further 
corroborated by the fact that, in rats, moderate recurrent hypogly-
cemia prevented age-related decline in hippocampal-related cogni-
tive functions (McNay et al., 2006), indicating that hippocampal 
neurons might functionally detect extracellular levels of glucose 
in this region.
We note that the Allen Mouse Brain Atlas1, a massive ISH project 
dedicated to map the brain expression of the mouse genome, also 
displays expression maps for Tas1r genes. However, we believe 
that our expression analyses add considerably to the brain maps 
reported in the atlas. First, it is not possible to visualize, from the 
rather weak and diffuse patterns displayed in the atlas, the expres-
sion of hypothalamic taste receptors in proximity to the ventral part 
of the third ventricle. Among these hypothalamic regions, we must 
mention as of great interest the paraventricular and arcuate nuclei 
of the hypothalamus. The expression of taste receptor signals in 
these hypothalamic regions known to be involved in neuroendo-
crine control strongly suggests a role for these molecules as glucose 
sensors in the brain (Porterﬁ  eld and White, 2007). A similar obser-
vation holds for structures such as the habenula and the choroid 
plexus. Another crucial piece of information deriving from our IHC 
analyses – that cannot be readily obtained from the atlas – refers 
to the neuronal expression of taste receptor proteins. In fact, our 
analysis is the ﬁ  rst one, to our knowledge, to indicate that nutrient 
sensing in the brain via taste-like signaling pathways might directly 
inﬂ  uence electrical neuronal activity. This is particularly relevant 
for the identiﬁ  cation of the chemosensors that have the ability 
to induce hormone release from neuroendocrine neurons of the 
paraventricular and arcuate nuclei of the hypothalamus during low 
glycemic levels (see above).
Finally, the results from our in vivo and cell culture experi-
ments indicate that the expression levels of the genes that code 
for G-  protein sweet receptors are under the control of nutritional 
status. On one hand, our in vivo experiments have shown that 
nutritional deﬁ  ciency and excess produce opposing effects on the 
expression levels of Tas1r1 and Tas1r2, with states of nutrient deﬁ  -
ciency being associated with upregulation of transcript levels while 
the opposite effect on gene levels was observed in obese, hyperglyc-
emic mice. However, it could be argued that such effects depended 
not on neuronal nutrient sensing per se, but rather on non-speciﬁ  c 
systemic effects produced for example by chronic nutrient excess. To 
resolve the issue of whether nutrient sensing occurs in neuronal cells 
expressing taste receptors independently of systemic factors or syn-
aptic contact, we have compared the expression levels of taste genes 
in cultured hypothalamic cells exposed to a severely hypoglycemic 
(0.1 mM) medium to those observed in cells exposed to higher glu-
cose levels including eu- and hyperglycemic concentrations (from 
0.5 up to 10 mM). Consistent with our in vivo studies, increasing 
glucose levels in the culture medium produced a signiﬁ  cant reduc-
tion in the expression levels of the sweet-speciﬁ  c gene Tas1r2, but 
not of the other receptor genes (since in these experiments only 
glucose, but not other nutrients including l-amino acids, levels 
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were manipulated). Although our experiments with cultured cells 
showed that Tas1r2 levels do not seem to change in strict accord-
ance (i.e., linearly) to ﬂ  uctuations in extracellular glucose, these 
experiments demonstrate that this membrane receptor gene does 
function as a sensor whose expression levels change according to 
whether glucose levels deviate from euglycemic concentrations. 
In particular, we have shown that hypothalamic cells exposed to 
hyperglycemic (5 and 10 mM glucose) media express considerably 
lower levels of Tas1r2 compared to the cells exposed to euglycemic 
(1.5 and 2.5 mM) media. This ﬁ  nding might shed further light on 
the mechanisms underlying deﬁ  cient central regulation of glucose 
homeostasis in obese subjects (Elmquist et al., 2005).
The above effects of extracellular glucose concentrations on 
Tas1r2 expression levels did not depend on intracellular metabolism 
of glucose. In fact, the ﬁ  nding that adding the non-metabolizable 
artiﬁ  cial sweetener sucralose to the cultured cells medium resulted 
in lower expression levels of Tas1r2, the only sweet-speciﬁ  c gene, 
but not others, suggest that brain glucosensing might be partially 
mediated by taste-like signaling pathways that do not depend on 
metabolic actions of GK, the enzyme considered to function as the 
primary glucosensor in neurons (Karschin et al., 1997). Our ﬁ  nd-
ings are consistent with several lines of evidence suggesting that 
glucosensing neurons might use alternative, GK/KATP-independent 
pathways to respond to local ﬂ  uctuations in glucose levels (reviewed 
in Gonzalez et al., 2008, 2009). Further studies must determine 
the extent to which intracellular glucose metabolism might inter-
act with membrane receptors in regulating neuronal responses to 
extracellular levels of glucose.
Another noticeable aspect of our cell culture experiments relates 
to the fact that whereas changes in glucose levels or addition of 
sucralose to the culture medium strongly modulated Tas1r2 expres-
sion levels, no such changes were detected in Tas1r3 levels. This 
result is certainly intriguing given the fact that the sweet taste recep-
tor for glucose is the heterodimer T1R2/T1R3. However, some of the 
characteristics of T1R3 function might provide some explanation 
for why no signiﬁ  cant variations in Tas1r3 levels were detected as 
a function of changes in glucose concentrations. It must be noted 
initially that T1R3 is not a sensory-speciﬁ  c taste gene product; 
rather, T1R3 has the ability to form dimers with both T1R1 and 
T1R2, shaping two receptors that, in turn, are sensitive to separate 
classes of chemicals (Zhao et al., 2003). T1R1 and T1R2, on the 
other hand, seem to form dimers exclusively with T1R3. In fact, to 
our knowledge, no functional T1R1/T1R2 dimers have ever been 
detected in tongue or other tissue (Zhao et al., 2003). One could 
therefore expect that changes in the levels of a certain nutrient can 
signiﬁ  cantly regulate expression levels of a taste gene only to the 
extent that the gene is speciﬁ  cally associated with the detection of 
that nutrient. In the case of our experiments using hypothalamic 
cells lines, changes in glucose levels were induced while leaving 
l-amino acid levels unaltered. This might be sufﬁ  cient to prevent 
the detection of signiﬁ  cant changes in expression levels of Tas1r3 
since quantitative PCR methods can only determine the overall 
levels of a given transcript. The above could also explain why in 
these hypothalamic cells experiments Tas1r2 levels were robustly 
modulated by glucose while large, although non-signiﬁ  cant, vari-
ations in Tas1r3 were observed. This observation is in addition 
consistent with the fact that Tas1r1 levels did not respond to changes 
in glucose levels. Second, T1R3, unlike T1R1 and T1R2, seems to 
also have the ability to form T1R3/T1R3 homodimers (Zhao et al., 
2003). In particular T1R3/T1R3 homodimers display sensitivity 
to sugars only at relatively high concentrations, e.g., >100 mM 
(Zhao et al., 2003), which is certainly outside the limits of physi-
ological glucose concentrations in the brain. Although we cannot 
ascertain, based on transcript levels, that such dimers are expressed 
in neurons, this is potentially another factor contributing to the 
insensitivity of Tas1r3 levels to variations of glucose in the brain 
at physiological limits. Third, we ﬁ  nally note that T1R3 has been 
recently implicated in calcium detection by taste cells (Tordoff et al., 
2008). Because calcium also acts as a nutritional signal in the brain 
(Ruat et al., 1995), it is possible that our experimental treatments 
did not robustly affect Tas1r3 expression levels because calcium lev-
els have not been explicitly manipulated as an experimental factor. 
In summary, the lack of speciﬁ  city of T1R3 to any particular class of 
nutrients might preclude detection of overall changes in transcript 
levels of Tas1r3 in response to the experimental treatments used 
in our study. We furthermore conjecture that a pervasive change 
in nutrient concentrations in the brain, involving ﬂ  uctuations in 
glucose, l- and d-amino acids, and ionic minerals such as calcium 
and magnesium, are required to produce sizeable changes in brain 
Tas1r3 levels. We conclude with the speculation that changes in 
Tas1r2 following variations in brain glucose might enhance the 
ability of T1R2 to “compete” for dimer formation with T1R3 in 
detriment of T1R1, although such conjecture has no experimental 
support at this point.
A similar issue is posed by the lack of signiﬁ  cant effects on taste 
G-protein genes expression levels by changes in nutrient levels. 
In fact, it appears that all signaling mechanisms downstream to 
taste G-protein coupled receptors are shared by different classes of 
chemicals. This holds for the case of both the taste phospholipase 
PLCβ2 and the non-selective ionic taste channel TRPM5, the dele-
tion of which induces severe impairments in sweet, umami and 
bitter transduction (Zhang et al., 2003). Similarly, the G-protein 
gustducin seems to be important not only for sweet taste signaling, 
but also for umami and bitter detection (Margolskee et al., 2007). 
Therefore, and likewise the T1R3 case presented above, the fact 
that taste G-proteins might be part of the transduction pathways 
of different taste qualities might have precluded us from detecting 
changes in these molecules based on analyses of transcript levels.
In summary, our study provided the ﬁ  rst line of evidence that 
G-protein coupled taste receptors might operate as membrane-
bound chemosensors in brain, and in particular that the sweet 
T1R2/T1R3 receptor is a candidate to be associated with the elusive 
brain glucose receptor.
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